Codes ATC:
P01BC01
EMLc
Indication
Malaria due to Plasmodium falciparum
Code ICD11:
1F40
Type de médicament
Chemical agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Additional notes
For use only in the management of severe malaria
Formulations
Parenteral > General injections > IV:
300 mg per mL in 2 mL ampoule (hydrochloride) solution for infusion ;
60 mg per mL in 2 mL ampoule (hydrochloride) solution for infusion
(EMLc)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of quinine solution for infusion 60 mg/mL to the EMLc for use in the management of severe malaria;
- the deletion of quinine tablet 300 mg from the EML and EMLc;
- an amendment to the footnote to specify use only in the management of severe malaria;
- to modify the formulation descriptions to better describe the available dosage forms.